Volume 7 Supplement 2

13th Scientific Symposium of the Austrian Pharmacological Society (APHAR). Joint Meeting with the Austrian Society of Toxicology (ASTOX) and the Hungarian Society for Experimental and Clinical Pharmacology (MFT)

Open Access

C-terminal splicing reveals intramolecular gating modulation in CaV1.3 L-type Ca2+ channels

  • Anamika Singh1,
  • Mathias Gebhart1,
  • Reinhard Fritsch2,
  • Jean-Charles Hoda1,
  • Martina Sinnegger-Brauns1,
  • Christoph Romanin2,
  • Jörg Striessnig1 and
  • Alexandra Koschak1Email author
BMC Pharmacology20077(Suppl 2):A11

DOI: 10.1186/1471-2210-7-S2-A11

Published: 14 November 2007

Neuronal excitability and pace-making in the sinoatrial node are controlled by low-voltage activated CaV1.3 L-type Ca2+ channels. We recently found that in related CaV1.4 channels a highly-structured distal C-terminal motif (CTM) modulates voltage- and Ca2+-dependent gating (CDI). In CaV1.3, C-terminal splicing leads to a full-length (CaV1.3L) and at least 1 short (CaV1.3S) splice form. If a CTM would also modulate CaV1.3 gating it would be present in CaV1.3L but not CaV1.3S variants. We therefore compared the biophysical properties of CaV1.3L or CaV1.3S coexpressed with β3 + α2δ-1 in tsA-201 cells using the whole-cell patch-clamp technique. CaV1.3S channels activated at more negative potentials compared to CaV1.3L (~ -10 mV, p < 0.0001), inactivated faster (p < 0.01) and showed more CDI (p < 0.01). These changes resulted in a decreased window current shifted to more hyperpolarized potentials likely to cause a reduction in the channels' dynamic range. Removal of the C-terminal 158 (CaV1.3Δ1158) or 76 amino acids was sufficient to induce gating properties similar to CaV1.3S. FRET experiments revealed interaction of the last 158 amino acids (C158) to a proximal C-terminal domain in CaV1.3L. Coexpression of C158 with CaV1.3Δ1158 completely restored CaV1.3L gating properties confirming this protein interaction. Thus CaV1.3 channel gating is under control of the distal C-terminus allowing alternative splicing to fine-tune channel activity and adapt channel function to physiological needs.

Authors’ Affiliations

(1)
Pharmacology and Toxicology, Department of Pharmacy, University of Innsbruck
(2)
Department of Biophysics, University of Linz

Copyright

© Singh et al; licensee BioMed Central Ltd. 2007

This article is published under license to BioMed Central Ltd.

Advertisement